for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

Combined Sputnik V, AstraZeneca vaccine's interim trial results due in two months - Ifax

MOSCOW, March 24 (Reuters) - Interim trial results of a vaccine against COVID-19 combining Russia’s Sputnik V and Britain’s AstraZeneca shots are expected in two months, the Interfax news agency cited Russia’s RDIF sovereign wealth fund chief as saying on Wednesday.

Kirill Dmitriev, the head of RDIF, which is marketing Sputnik V across the world, said trials of the combined vaccine would start next week in the United Arab Emirates, Interfax reported. (Reporting by Polina Ivanova; Writing by Tom Balmforth; Editing by Alison Williams)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up